Enveric Biosciences, Inc.

NASDAQ (USD): Enveric Biosciences, Inc. (ENVB)

Last Price

0.441

Today's Change

-0.042 (8.71%)

Day's Change

0.411 - 0.474

Trading Volume

434,000

Overview

Market Cap

3 Million

Shares Outstanding

8 Million

Avg Volume

1,385,153

Avg Price (50 Days)

0.49

Avg Price (200 Days)

0.78

PE Ratio

-0.13

EPS

-3.49

Earnings Announcement

11-Nov-2024

Previous Close

0.48

Open

0.47

Day's Range

0.4111 - 0.474

Year Range

0.361 - 2.92

Trading Volume

438,698

Price Change Highlight

1 Day Change

-8.69%

5 Day Change

0.92%

1 Month Change

-10.30%

3 Month Change

-9.18%

6 Month Change

-53.04%

Ytd Change

-65.04%

1 Year Change

-78.62%

3 Year Change

-99.53%

5 Year Change

-99.94%

10 Year Change

-99.99%

Max Change

-100.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment